Interestingly, they also found that hypoxia strongly increased PSMA expression in breast cancer cells, which could be approached by administering PSMA therapy in a hypo-fractionated way, with the first fraction targeting PSMA-expressing endothelial cells and, in this way, decreasing the oxygen supply (38). This evidence concerns the gene FOLH1 and breast cancer.